National plaintiffs' law firm Berger Montague PCannounces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“LifeMD” or the “Company”) on behalf of investors who purchased or acquired shares during the period fromMay 7, 2025 through August 5, 2025 (the “Class Period”).
https://mma.prnewswire.com/media/232479/berger_montague.jpg
Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.
LifeMD, headquartered in New York, New York, provides virtual medical services and prescription delivery.
The lawsuit accuses the Company of overstating its competitive position and issuing unrealistic 2025 financial guidance. According to the complaint, LifeMD failed to disclose increasing customer acquisition costs tied to its RexMD platform and its efforts to promote obesity medications such as Wegovy and Zepbound. The lawsuit claims that LifeMD's statements throughout the Class Period were materially false and misleading and lacked a reasonable basis, ultimately resulting in significant investor losses when the market learned the truth.
If you are a LifeMD investor and would like to learn more about this action, CLICK HEREor please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865.
About Berger MontagueBerger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigationsince its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:Andrew AbramowitzSenior CounselBerger Montague(215) 875-3015aabramowitz@bergermontague.com
Caitlin AdorniDirector of Portfolio and Institutional Client Monitoring ServicesBerger Montague(267) 764-4865cadorni@bergermontague.com
https://edge.prnewswire.com/c/img/favicon.png?sn=DC71772&sd=2025-09-11
View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-notice-berger-montague-advises-lifemd-inc-nasdaq-lfmd-investors-to-inquire-about-a-securities-fraud-class-action-302554408.html
SOURCE Berger Montague
https://rt.newswire.ca/rt.gif?NewsItemId=DC71772&Transmission_Id=202509111706PR_NEWS_USPR_____DC71772&DateId=20250911